Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

Condensed Statements of Cash Flows (Unaudited) - USD ($)
8 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2022
Cash Flows from Operating Activities:    
Net income (loss) $ (1,086,499) $ 9,859,181
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Formation cost paid by Sponsor in exchange for issuance of Founder Shares 5,000
Transaction costs allocated to warrants associated with the Initial Public Offering 373,194
Change in the fair value of warrant liability 673,667 (9,399,334)
Unrealized loss on marketable securities held in Trust Account 37,288
Interest earned on investments held in Trust Account (1,561,870)
Changes in operating assets and liabilities:    
Prepaid expenses (627,088) 12,039
Accounts payable and accrued expenses 241,257
Accrued offering costs 6,965 (1,098)
Other noncurrent assets 233,482
Net cash used in operating activities (654,761) (579,055)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (236,900,000)
Net cash used in investing activities (236,900,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 225,400,000
Proceeds from sale of Private Placement Warrants 14,500,000
Proceeds from promissory note – related party 132,446
Payment of offering costs (739,341)
Net cash provided by financing activities 239,293,105
Net Change in Cash 1,738,344 (579,055)
Cash – Beginning 1,486,972
Cash – Ending 1,738,344 907,917
Non-Cash Investing and Financing Activities:    
Offering costs included in accrued offering costs 3,598
Offering costs paid by Sponsor in exchange for issuance of founder shares 20,000
Initial classification of ordinary share subject to possible redemption 236,900,000
Deferred underwriting fee payable 8,050,000
Accretion of Class A ordinary share subject to possible redemption $ 1,524,582